xanthophyll Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Xanthophylls are yellow pigments that occur widely in nature and form one of two major divisions of the carotenoid group; the other division is formed by the carotenes. The name is from Greek xanthos and phyllon, due to their formation of the yellow band seen in early chromatography of leaf pigments.   Wikipedia

Chemistry

  • SMILES: C\C(=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C)\C=C\C=C(/C)\C=C\[C@H]2C(=C[C@H](O)CC2(C)C)C
  • InChIKey: KBPHJBAIARWVSC-RGZFRNHPSA-N
  • Mol. Mass: 568.89
  • ALogP: 10.4
  • ChEMBL Molecule:
    lutein  
More Chemistry

Pharmacology

Alternative names

leutein | lutein | utein | xanthophyll | xantofyl

Organizations (44)

Research & Development (44)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (13)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (13)


 

Carotid Artery Diseases (Phase 3)

Cataract (Phase 3)

Central Serous Chorioretinopathy (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Diabetic Retinopathy (Phase 2)

Genetic Diseases, Inborn (Phase 2)

Healthy Volunteers (Phase 2)

Infant, Newborn, Diseases (Phase 1/Phase 2)

Macula Lutea (Phase 4)

Macular Degeneration (Phase 3)

Parenting (Phase 3)

Retinitis Pigmentosa (Phase 3)

Vision, Entoptic (Phase 2/Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 32
  • # of Trial Organizations: 44

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue